A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
מצבים רפואיים
Locally Advanced or Metastatic Solid Tumors · NSCLC · HNSCC · Melanoma · TNBC · Esophageal Cancer · Gastric Cancer · Cervical Cancer · Colorectal Cancer · Urothelial Carcinoma · Clear Cell RCC · HCC
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Stanford University, San Francisco, California, United States
University Of Colorado, Aurora, Colorado, United States
Florida Cancer Specialists - Sarasota, Sarasota, Florida, United States
Winship Cancer Institute, Atlanta, Georgia, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Henry Ford Hospital, Detroit, Michigan, United States
Washington University Medical Center, Division of Oncology, St Louis, Missouri, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
The West Clinic - Memphis (Union Ave), Germantown, Tennessee, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
IDS (IDS) Pharmacist South Texas Accelerated Resear Therapeutics, LLC START, San Antonio, Texas, United States
Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia
Monash Health Monash Medical Centre, Clayton, Victoria, Australia
Linear Clinical Research Ltd, Nedlands, Western Australia, Australia
UZ Antwerpen, Edegem, Belgium
CHU de Liège, Herstal, Belgium
GasthuisZusters Antwerpen, Wilrijk, Belgium
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
University General Hospital ''ATTIKON'' - General Hospital of West Attica H AGIA VARVARA, Chaïdári, Attica, Greece
Papageorgiou General Hospital of Thessaloniki, N. Efkapria-Pavlos Melas, Thessaloniki, Greece
Sotiria Thoracic Diseases Hospital of Athens, Athens, Greece
Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
Universitair Medisch Centrum Groningen, Groningen, Netherlands
Seoul National University Hospital, Seoul, South Korea
Asan Medical Center - PPDS, Seoul, South Korea
Samsung Medical Center - PPDS, Seoul, South Korea
Severance Hospital Yonsei University Health System - Clinical Trials Center Pharmacy, Seoul, South Korea
ICO l?Hospitalet ? Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain
Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona, Spain
START MADRID_Hospital Universiario Fundacion Jimenez Diaz, Madrid, Spain
Hospital Universitario 12 De Octubre, Madrid, Spain
Hospital Universitario Virgen de la Victoria, Málaga, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden
Karolinska Universitetssjukhuset Solna, Stokholm, Solna, Sweden
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Taiwan
Chung Shan Medical University Hospital, Taichung, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
מובילי המחקר
Clinical Trials
Study Director
Genentech, Inc.